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Summary: Since the introduction of H2-receptor antagonists， the incidence of ulcer 
surgery has decreased markedly. Based on the number of patients who underwent ulcer 
surgery and upper gastrointestinal endoscopy in our hospital， the number of operations for 
peptic ulcer disease has decreased， although the number of peptic ulcer patients diagnosed 
by endoscopy has increased after the introduction of cimetidine (the first H2-receptor 
antagonist in ]apan). The decreasing rate of surgical therapy before and after the 
administration of H2-receptor antagonists was 49.1%. The number of emergency opera-
tions has also decreased among ulcer patients diagnosed by endoscopy although the number 
of perforated and bleeding ulcer patients has increased. It is also reported that the most 
common operat~ve procedure for both gastric and duodenal ulcer was distal gastrectomy 
reconstructed by gastroduodenostomy (Bi1roth 1). 
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INTRODUCTION 
Since the introduction of H2-receptor antagonists， a marked decrease in the incidence of elective 
surgery and no significant decrease in the number of operations for perforated or bleeding ulcer have 
been reported')-6). In the J apanese literature too， it is reported that the number of operations， which 
include emergency surgery， has clearly decreased and the incidence of operation for perforated ulcer 
has not decreased7).8). However， recently the number of patients with peptic ulcer in Japan has 
gradually increased9). Endoscopic examination in our hospital also showed that the number of ulcer 
patients has incteased. The aim of this study was to clarify the actual condition of peptic ulcer before 
and after the introduction of cimetidine and also to discuss the treatment of peptic ulcer disease. 
PATIENTS AND METHODS 
From 1977 to 1982， 3，940 patients were diagnosed as having peptic ulcer by upper gastrointestinal 
endoscopy， and 368 of them underwent ulcer surgery in Saiseikai Chuwa Hospital (323 Abe， Sakurai-
city， Nara-prefecture， Japan). The ag田 ofthe patients who underwent endoscopy ranged from 8 to 92 
years， with a mean of 49園7years. The male to female ratio was 3. 0: l. Patients who underwent ulcer 
surg巴rywere not always examined by endoscopy in our hospital. On the other hand， the ages of the 
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patients who underwent surgery ranged from 15 to 91 years， with a mean of 44.3 years. The male to 
female ratio was 4. 2: 1. 
The trend for the incidence of surgery was calculated based on the number of patients whose 
diagnosis of ulcer was confirmed by upper gastrointestinal endoscopy from 1977 to 1987 in our hospital. 
The total number of operations performed between 1977 and 1981 was compared with that between 1983 
and 1987. The number of operations in 1982 was exc1uded， because the year 1982 was considered to b巴
the year for the turning point of ulcer medication. 
For statistical evaluation of differences， Student's t test and chi square test were used. Statistical 
significance was accepted at the 5% level. 
RESULTS 
The incidence of patients with peptic ulcer dianosed by upper gastrointestinal endoscopy was almost 
constant， but increased in those three years (Fig. 1). In 3，940 ulcer patients diagnosed by endoscopy 
during the study period， 2，617 had gastric ulcer (66.4%)， 828 had duodenal ulc巴r(21.0%) and 495 had 
gastric and duodenal ulcer (12.6%). However， the number of ulcer operations gradually decreased 
after the introduction of H2-receptor antagonists (Fig. 2). Of the 368 patiens who underweIlt surgery， 
187 had gastric ulcer (50.8%)， 157 had duodenal ulcer (42.7%) and 24 had gastric and duodenal ulcer 
(11.7%). 
The total number of operations before and after H2-receptor antagonist therapy was 220 and 112， 
respectively. The decreasing rate of peptic ulcer operation before and after H2-receptor antagonist 
therapy was 49.1%. This was statistically significant. During the period b巴foreH2-receptor antagonist 
therapy， the number of operations for gastric ulcer was 122. On the contrary， the number after H2 
receptor antagonist therapy was only 4. This was a statistically significant decrease. The number of 
operations for duodenal ulcer was much greater than that of gastric ulcer in recent years. The 
op巴rationrate of peptic ulcer has decreased markedly after the introduction of H2-receptor antagonists 
(Fig. 3). As far as the complication of peptic ulcer is concerned， bleeding in gastric ulcer and 
perforation in duodenal ulcer are the most significant. N everth巴less，the rate of complication decreas巴d
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Fig. 1. Number of uIcer patients diagnosed by endoscopy. 
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Fig. 3. The operation rate of peptic u1cer. 
among ulcer patients diagnosed by endoscopy. How巴verit has increased among the patients who 
und巴rwentsurgery (Table 1). 
The method of operation performed on almost al the peptic ulcers， which include both gastric and 
duodenal ulcers， was distal gastrectomy reconstructed by gastroduodenostomy or gastrojejunostomy. 
In the case of perforated ulcer too， distal gastrectomy was usually performed. In 289 of 368 ulcer 
operations (78.5%)， distal gastrectomy was reconstructed by gastroduodenostomy， and in 63 of 368 (17. 
1%) reconstructed by gastrojejunostomy. Only one patient who had reconstruction by gastroduodenos-
tomy (0.3%) showed recurrence and thus the patient was reconstructed by gastrojejunostomy. 
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DISCUSSION 
In Western countries， the frequency of peptic u1cer s巴emedto have reached its peak frequency in the 
middle of the 1950's and duodenal u1cer was more common than gastric u1cer between the First and 
Second World Wars10). In Japan， the incidence of gastric u1cer was 314.5 per 100，000 inhabitants in 1970 
and 500.0 per 100，000 in 1984， while the incidences of duodenal u1c巴rwere 148.3 and 204.5 resp巴ctively9).
These results suggest that p巴pticu1cer did not se巴mto have reached its peak in J apan. In our hospital， 
peptic u1cer showed an increase in frequency in recent years and gastric u1cer was more common than 
duodenal u1cer throughout the study period. 
As for u1cer surgery， N agao and associate reported the results of an investigation from 452 hospitals 
in J apan from 1977 to 198611). According to one of their results， as shown in Table 2， the decreasing rate 
of surgery was 43.3%. During the period after H2-receptor antagonist therapy， bleeding in gastric u1cer 
and perforation in duodenal u1cer were also significant complications. In recent years， more than half 
of th巴operationsin Japan were performed due to bleeding of perforation. It was due to the trend that 
many peptic u1cer patients， when advised to have surgical treatment， refused on the ground that they 
would prefer to continue with cimetidine therapy12). Consequ巴nt1y，the indications of operation for 
peptic u1cer disease after H2-receptor antagonist therapy is indicated only when there is gastric out1et 
obstruction and perforation. H2-receptor antagonists have made the pepticu1cer operation a less 
Table 1. The incidence of operation for bleeding and perforated gastric and duodenal ulcer before and after 
H2-receptor antagonist therapy (H2-RA) 
Before H2-RA(1977-81) After H2-RA(1983-87) 
(Among operation/u1cer pati巴nts(%)) 
Gastric u1cer Bleeding 18 (14.8/2.1) 16 (36.4 * 11.0勺
Perforation 2 (1.6/0.24) 2 (1.410.13) 
Duodenal u1cer Bleeding 7 (8.2/3.2) 2 (3.410.37*) 
P巴rforation 17 (20.0/7.8) 19 (32.8/3.5*) 
Total Bleeding 25 (12.1/2.3) 18 (17.6/0.84 ') 
Perforation 19 (9.2/1.8) 21 (20.6本10.98)
Statisticaly significant 
Table 2. The number of ulcer operation and the incidence of巴mergencyop巴rationbefore and after H2 
-receptor antagonist therapy (H2-RA) 
Before H2-RA(1977-81) After H2-RA(1983-87) 
Gastric ulcer 24，75 12，74 
Bleeding (%) 31.8 53.9* 
Perforation (%) 7.3 14.2* 
Duodenal 19，993 12，638 
Bleeding (%) 12.9 15.8本
Perforation (%) 30.6 47.6* 
Total 4，768 25，382 
Bleeding (%) 23.3 34.9* 
Perforation (%) 17.7 30.8市
Statisticaly significant 
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frequent and a more difficult one. In controlled trials to compare the valu巴ofH2-receptor antagonist 
therapy or operation， Anderson et al reported that the cumulative operation rate was more than 50% 
in patients treated with cimetidine within 24 months after initial treatmentI3)，14) They also advocated 
that the difference in economic consequences between a more active and a more conservative treatment 
scheme is so small， though the cimetidine therapy is found to be less expensive than surgery in previous 
reports同，16) The most important problem in peptic ulcer treatment is the so called “refractory" ulcer. 
Some controlled trials have been performed and the limit of conservative therapy for peptic ulcer has 
become clearI7)-19). Appropriate judgment of prognosis of refractory peptic ulcer is now required. 
The methods of operation for perforated peptic ulcer from the 1940's to 1970's in J apan have been 
precisely reported by Kaku20). The most common operative procedure for perforated peptic ulcer was 
extensive gastrectomy， which was responsible for 87.3% of ulcer surgery. Simple closure was only 7. 
6% and vagotomy with or without partial gastrectomy was 3.1%， although these procedures were 
popular in Western countries21). 
In conclusion， the number of elective and巴mergencyoperations for peptic ulcer has been decreasing 
after the introductidn of H2-receptor antagonists， although the number of peptic ulcer patiens has been 
increasing in J apan. This is thought to be the effect of H2-receptor antagonists. However， the problem 
of refractory ulcer remains. A more precise study of total treatment for peptic ulcer is required. 
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